CYCLONE 2: no impact on prostate cancer forecast. O'Reilly M, McDermott R. Lancet Oncol 2025;26:1400-1402.

Read + Share

Amedeo Smart

Independent Medical Education

O'Reilly M, McDermott R. CYCLONE 2: no impact on prostate cancer forecast. Lancet Oncol 2025;26:1400-1402.
PMID: 41167211